Zoë Betteridge

4.8k total citations
53 papers, 2.5k citations indexed

About

Zoë Betteridge is a scholar working on Epidemiology, Rheumatology and Immunology. According to data from OpenAlex, Zoë Betteridge has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 20 papers in Rheumatology and 17 papers in Immunology. Recurrent topics in Zoë Betteridge's work include Inflammatory Myopathies and Dermatomyositis (49 papers), Eosinophilic Disorders and Syndromes (17 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Zoë Betteridge is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (49 papers), Eosinophilic Disorders and Syndromes (17 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Zoë Betteridge collaborates with scholars based in United Kingdom, United States and Hungary. Zoë Betteridge's co-authors include Neil McHugh, Harsha Gunawardena, NJ McHugh, Sarah Tansley, J. North, Lucy R. Wedderburn, Hector Chinoy, Robert G. Cooper, Gavin Shaddick and Katie Arnold and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Journal of Internal Medicine.

In The Last Decade

Zoë Betteridge

52 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoë Betteridge United Kingdom 26 2.2k 1.4k 644 575 422 53 2.5k
Harsha Gunawardena United Kingdom 21 1.6k 0.7× 1.1k 0.8× 435 0.7× 417 0.7× 290 0.7× 51 1.9k
Sarah Tansley United Kingdom 18 1.4k 0.6× 887 0.6× 406 0.6× 332 0.6× 217 0.5× 50 1.6k
Edward P. Trieu United States 10 737 0.3× 522 0.4× 263 0.4× 262 0.5× 148 0.4× 13 1.0k
Hemlata Varsani United Kingdom 20 607 0.3× 571 0.4× 891 1.4× 399 0.7× 68 0.2× 31 1.7k
Jean‐Luc Charuel France 13 742 0.3× 409 0.3× 216 0.3× 217 0.4× 147 0.3× 24 945
M Błaszczyk Poland 25 336 0.1× 733 0.5× 307 0.5× 294 0.5× 502 1.2× 87 2.0k
J. North United Kingdom 7 736 0.3× 490 0.4× 180 0.3× 194 0.3× 142 0.3× 9 835
Masanari Kodera Japan 18 532 0.2× 521 0.4× 437 0.7× 180 0.3× 244 0.6× 40 1.5k
Antoine de Mascarel France 24 240 0.1× 231 0.2× 207 0.3× 195 0.3× 161 0.4× 52 1.9k
K Hollowood United Kingdom 21 350 0.2× 311 0.2× 271 0.4× 141 0.2× 449 1.1× 47 1.5k

Countries citing papers authored by Zoë Betteridge

Since Specialization
Citations

This map shows the geographic impact of Zoë Betteridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoë Betteridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoë Betteridge more than expected).

Fields of papers citing papers by Zoë Betteridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoë Betteridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoë Betteridge. The network helps show where Zoë Betteridge may publish in the future.

Co-authorship network of co-authors of Zoë Betteridge

This figure shows the co-authorship network connecting the top 25 collaborators of Zoë Betteridge. A scholar is included among the top collaborators of Zoë Betteridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoë Betteridge. Zoë Betteridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tansley, Sarah, Danyang Li, Zoë Betteridge, & Neil McHugh. (2020). The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Lara D. Veeken. 59(8). 2109–2114. 78 indexed citations
2.
Betteridge, Zoë, Hector Chinoy, Jiří Vencovský, et al.. (2019). Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis. Lara D. Veeken. 59(5). 1026–1030. 13 indexed citations
3.
Tansley, Sarah, Zoë Betteridge, Hui Lu, et al.. (2019). The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients. Lara D. Veeken. 59(7). 1626–1631. 15 indexed citations
4.
Betteridge, Zoë, Sarah Tansley, Gavin Shaddick, et al.. (2019). Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. Journal of Autoimmunity. 101. 48–55. 180 indexed citations
5.
Bodoki, Levente, et al.. (2018). Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.. PubMed. 40(4). 337–47. 4 indexed citations
6.
Betteridge, Zoë, Lynsey Priest, Robert G. Cooper, et al.. (2018). Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer. Arthritis Research & Therapy. 20(1). 176–176. 9 indexed citations
7.
8.
Tansley, Sarah, Zoë Betteridge, Stefania Simou, et al.. (2016). 174 A Diagnostic and Treatment Challenge: The Prevalence and Clinical Associations of Anti-HMG-CoA Reductase Autoantibodies in a Large UK Juvenile-Onset Myositis Cohort. Lara D. Veeken. 55(suppl_1). i132–i133. 2 indexed citations
9.
Klein, Martin, H. Mann, Lenka Pleštilová, et al.. (2015). Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Lara D. Veeken. 54(11). 2010–2014. 51 indexed citations
10.
11.
Klein, Martin, H. Mann, Lenka Pleštilová, et al.. (2014). Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations. The Journal of Rheumatology. 41(6). 1133–1139. 19 indexed citations
12.
Tansley, Sarah, Zoë Betteridge, Harsha Gunawardena, et al.. (2012). Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies.. UCL Discovery (University College London). 1 indexed citations
13.
Betteridge, Zoë, Hector Chinoy, Jiří Vencovský, RG Cooper, & Neil McHugh. (2011). Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients. Lara D. Veeken. 50. 105–106. 2 indexed citations
14.
Chinoy, Hector, Hazel Platt, Noreen Fertig, et al.. (2011). Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Lara D. Veeken. 51(5). 794–799. 24 indexed citations
15.
Chinoy, Hector, Debbie Payne, Kay Poulton, et al.. (2009). HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Lara D. Veeken. 48(10). 1213–1217. 28 indexed citations
16.
Betteridge, Zoë, Harsha Gunawardena, Hector Chinoy, et al.. (2008). Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Annals of the Rheumatic Diseases. 68(10). 1621–1625. 137 indexed citations
17.
Chinoy, Hector, Hazel Platt, Janine A. Lamb, et al.. (2008). The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis & Rheumatism. 58(10). 3247–3254. 41 indexed citations
18.
Gunawardena, Harsha, Lucy R. Wedderburn, J. North, et al.. (2007). Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Lara D. Veeken. 47(3). 324–328. 156 indexed citations
19.
Betteridge, Zoë, et al.. (2007). Identification of a novel autoantibody directed against small ubiquitin‐like modifier activating enzyme in dermatomyositis. Arthritis & Rheumatism. 56(9). 3132–3137. 107 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harsha Gunawardena Breakdown of academic impact, for papers by Sarah Tansley Breakdown of academic impact, for papers by Edward P. Trieu Breakdown of academic impact, for papers by Hemlata Varsani Breakdown of academic impact, for papers by Jean‐Luc Charuel Breakdown of academic impact, for papers by M Błaszczyk Breakdown of academic impact, for papers by J. North Breakdown of academic impact, for papers by Masanari Kodera Breakdown of academic impact, for papers by Antoine de Mascarel Breakdown of academic impact, for papers by K Hollowood
Rankless by CCL
2026